Literature DB >> 26895343

Measuring Signal Detection Performance: Can We Trust Negative Controls and Do We Need Them?

Jim Slattery1.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 26895343     DOI: 10.1007/s40264-016-0407-z

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  2 in total

1.  Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP).

Authors:  Manfred Hauben; Jeffrey K Aronson; Robin E Ferner
Journal:  Drug Saf       Date:  2016-05       Impact factor: 5.606

Review 2.  Defining a reference set to support methodological research in drug safety.

Authors:  Patrick B Ryan; Martijn J Schuemie; Emily Welebob; Jon Duke; Sarah Valentine; Abraham G Hartzema
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

  2 in total
  3 in total

1.  On Designs for Vaccine Surveillance.

Authors:  Robert W Platt
Journal:  Drug Saf       Date:  2016-12       Impact factor: 5.606

2.  The Impact of Mandatory Reporting of Non-Serious Safety Reports to EudraVigilance on the Detection of Adverse Reactions.

Authors:  Gianmario Candore; Sebastian Monzon; Jim Slattery; Loris Piccolo; Rodrigo Postigo; Xavier Xurz; Sabine Strauss; Peter Arlett
Journal:  Drug Saf       Date:  2021-12-08       Impact factor: 5.606

3.  Detecting early safety signals of infliximab using machine learning algorithms in the Korea adverse event reporting system.

Authors:  Jeong-Eun Lee; Ju Hwan Kim; Ji-Hwan Bae; Inmyung Song; Ju-Young Shin
Journal:  Sci Rep       Date:  2022-09-01       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.